GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (BOM:532531) » Definitions » Dividend Payout Ratio

Strides Pharma Science (BOM:532531) Dividend Payout Ratio : 0.24 (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Strides Pharma Science Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Strides Pharma Science's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.24.

The historical rank and industry rank for Strides Pharma Science's Dividend Payout Ratio or its related term are showing as below:

BOM:532531' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09   Med: 0.47   Max: 4.54
Current: 0.13


During the past 13 years, the highest Dividend Payout Ratio of Strides Pharma Science was 4.54. The lowest was 0.09. And the median was 0.47.

BOM:532531's Dividend Payout Ratio is ranked better than
90.95% of 431 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs BOM:532531: 0.13

As of today (2024-12-14), the Dividend Yield % of Strides Pharma Science is 0.35%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Strides Pharma Science was 4.93%. The lowest was 0.11%. And the median was 0.44%.

Strides Pharma Science's Dividends per Share for the months ended in Sep. 2024 was ₹2.50.

During the past 12 months, Strides Pharma Science's average Dividends Per Share Growth Rate was 66.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -9.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Strides Pharma Science was 55.40% per year. The lowest was -23.70% per year. And the median was 7.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Strides Pharma Science Dividend Payout Ratio Historical Data

The historical data trend for Strides Pharma Science's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science Dividend Payout Ratio Chart

Strides Pharma Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.09 - - -

Strides Pharma Science Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 - - - 0.24

Competitive Comparison of Strides Pharma Science's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Strides Pharma Science's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's Dividend Payout Ratio falls into.



Strides Pharma Science Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Strides Pharma Science's Dividend Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2024 )/ EPS without NRI (A: Mar. 2024 )
=1.5/ -1.694
=N/A

Strides Pharma Science's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=2.5/ 10.463
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Strides Pharma Science (BOM:532531) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Strides Pharma Science Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Strides Pharma Science Business Description

Traded in Other Exchanges
Address
Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076
Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market plan focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. The company's reportable segment are; Pharmaceutical & Bio-pharmaceutical.

Strides Pharma Science Headlines

No Headlines